The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Cochlear Limited has announced the launch of the Nucleus Profile Plus Series Cochlear implant.

This is designed for routine 1.5 and 3 Tesla magnetic imaging scans without the need to remove it.

This means someone with the implant doesn’t need to remove the internal magnet when going for an MRI which makes the process easier and quicker.

Cochlear has also released the Nucleus 7 Sound Processor which is currently the first and only implant which can be controlled from a phone.

The Nucleus Profile Series also includes the thinnest implants in the world and a range of electrodes individually suited which will significantly impact hearing.

Currently, it is only available in Germany with other European countries expected to follow in the coming months and other developed markets expecting to launch after regularity approvals.

Please find announcement attached here

COH by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Unith wraps up Q1 with $5M in cash as digital humans evolve

Unith has wrapped up Q1 of 2024 with nearly $5M in cash and opex reduced. But…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…